Table 1.

Table 1.

Selected Characteristics of Seven Studies that Examined the Treatment of de Quervain’s Tenosynovitis.

Study Characteristics	Weiss et al1 1994	Harvey et al2 1990	Anderson et al3 1991	Witt et al4 1991	McKenzie5 1972	Zingas et al6 1998	Christie7 1955
Women’s wrists	80	70	50	64	25	12	16
Men’s wrists	13	12	5	19	5	7	4
Bilateral	0	0	1	4	0	0	0
Mean age, years (range)	38 (17–72)	45 (16–83)	47 (21–80)	44 (16–75)	49.5 (25–74)	39 (24–63)	46 (18–74)
Demographics	No difference in treatment success when comparing sex, hand dominance, age, or duration of symptoms	Women with infants and small children, hand dominance, secretary, nursing occupation	Housework, clerical	No association found between sex, hand dominance, age, or duration	Not noted	Homemaker, barber, salesperson	Tailor, cutter, seamstress, poster artist
Criteria for diagnosis	Pain at radial wrist, tender over 1st dorsal compartment, Finkelstein’s test	Pain at radial wrist, tender over 1st dorsal compartment, Finkelstein’s test	Pain at radial wrist, tender over 1st dorsal compartment, Finkelstein’s test	Pain at radial wrist, tender over 1st dorsal compartment, Finkelstein’s test	Pain at radial wrist, tender over 1st dorsal compartment, Finkelstein’s test	Pain at radial wrist, tender over 1st dorsal compartment, Finkelstein’s test	Pain at radial wrist, tender over 1st dorsal compartment, Finkelstein’s test
Exclusion criteria	Not noted	Previous treatment	No previous steroid injection within past 6 months	Rheumatoid arthritis	Not performed	Previous wrist surgery, previous 1st extensor compartment injection, rheumatoid arthritis in pregnancy	No obvious preceding trauma
Duration of symptoms, mo (range)	7 (0.25–36)	3.2 (0.75–14)	4.4 (1–24)	5.35 (0.5–18)	1.25–9	3.9 (1–11)	8 (1–36)
Injection medicine used	1 cc betamethasone, 1 cc 1% lidocaine	Hydrocortisone acetate or methyl prednisolone acetate, “local” anesthetic	Methyl-prednisolone, 80 mg, 1% Xylocaine 1.5 cc	40 mg methyl-prednisolone, 1% lidocaine 1 cc	25 mg hydrocortisone, 2% lidocaine 1 cc	6 mg Celestone, 1% lidocaine 3 cc	25 mg hydrocortisone acetate, 2% procaine 1 cc
One injection	42	45	33	0	24	19	16
Repeated injection	0	7	14	0	5	0	4
Injection and splint	14	0	0	87	0	0	0
Thumb spica splint	37	0	39	0	0	0	0
NSAID	0	0	39	0	0	0	0
Rest	0	0	17	0	0	0	0
Definition of success	Absence of diagnostic criteria	Absence of diagnostic criteria	Absence of diagnostic criteria	Absence of diagnostic criteria	Absence of diagnostic criteria	Absence of diagnostic criteria	Absence of diagnostic criteria
Side effects	Not noted	2 nontender nodules, 2 skin color changes	Skin color changes and fat atrophy = 16, flare = 5	None	None	None	Superficial thrombo-phlebitis (1)
Failure	45 (underwent surgery)	11 (6 had 2 injections, 5 had 1 injection)	5	30 (within 3 months)	1	8 (3 had surgery, 5 had return of criteria)	1
Follow-up, mo (range)	4, 13 (6–14)	0.5, 20 (0.25–84)	1.5, 48 (6–71)	18 (12–30)	0.5, 1, 3, 18	1, 3	3.5